Solkotrihovak - Vaccines used to restore normal vaginal flora.

Pharmacological action

Active components included in the vaccine Solkotrihovak contribute activation of non-specific and specific immunity and regulate the vaginal flora.  Solkotrihovak-lyophilisate

As a result of increased levels Solkotrihovak humoral antibodies of class IgG, and the level of antibody sIgA-specific and total sIgA in vaginal secretions, which results in reducing the risk of re-infection caused by Trichomonas or other pathogenic bacteria.

Antibodies formed after applying Solkotrihovak, contribute to the restoration of normal microflora of the vaginal mucosa.

Product form

Solkotrihovak produced as a lyophilisate for suspension intended for intramuscular administration (in the form of a porous white tablets). One vial contains one dose of the drug, which includes 8 breeding strains coccoid form of freeze-dried lactobacilli:

  • 3 strain - L.rhamnosus and L.vaginalis;
  • 1 strain - L.fermentum and L.salivarius.

Included with the solvent - distilled water (0 5 mL).

Analogs Solkotrihovak

By analogues Solkotrihovak mode of action include:

  • Nasal spray - IRS 19;
  • The solution intramuscular injection - Psevdovak and Shigellvak.

Also to peers Solkotrihovak include suspension for subcutaneous administration: Vaccine staphylococcal (Stafilovaktsina) toxoid of Pseudomonas aeruginosa, Pseudomonas vaccine, vaccine gonococcal (Gonovaktsina) and a number of other drugs.

Indications Solkotrihovak

Solkotrihovak according to the instructions indicated for the treatment and prevention of recurrent disease:

  • Trichomoniasis in women;
  • Nonspecific bacterial vaginosis.


According to the instructions Solkotrihovak contraindicated to apply at:

  • Acute infectious diseases;
  • Hematopoietic system diseases, including acute leukemia;
  • Primary and secondary immunodeficiency states;
  • Active tuberculosis;
  • Renal and heart failure;
  • Hypersensitivity to the Solkotrihovak.

In the absence of clinical data on the safety of Solkotrihovak not recommended:

  • During the period of breast-feeding;
  • When pregnancy;
  • At the age of 15 years.

Dosing Solkotrihovak

Solkotrihovak should be administered intramuscularly (into the gluteal muscle).  Solkotrihovak-packaging

The full course consists of three injections, which are administered at intervals of 2 weeks.

A single revaccination Solkotrihovak further recommended every 2 years.

By weakening action may cause Solkotrihovak use of immunosuppressants, and radiation therapy.

No significant incompatibilities Solkotrihovak with other drugs were observed.

Solkotrihovak of instructions are not prescribed for sexually transmitted diseases (syphilis, gonorrhea).

Side effects Solkotrihovak

Solkotrihovak Review may lead to local reactions in the form of:

  • Mild erythema;
  • Pain at the injection site;
  • Puffiness.

Systemic reactions of reviews Solkotrihovak is rare. In some cases it is possible:

  • Increased body temperature, wearing short-term nature;
  • headache;
  • Chills;
  • Fatigue.

Allergic reactions Solkotrihovak Review usually does not cause. When they occur, as well as in the cases of other reactions the vaccine should be discontinued.

storage conditions

Solkotrihovak refers to prescription drugs that require storage in cold boxes (at a temperature of 15-25 ° C). Shelf life - 3 years.